Physician profile
Harold Mark Cotler
NPI 1659355832
$5,044.87
in general payments reported to CMS, 2019-2025
39 companies · $1,692 in 2025
The $1,692 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $591 · 2021: $459 · 2022: $451 · 2023: $726 · 2024: $589 · 2025: $1,692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,995 · Education: $12.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,994.57 |
| Education | $12.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,547.34 | 2024-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial, Gore Enform Intraperitoneal Biomaterial |
| Davol INC. | $620.72 | 2021-2022 | |
| Abbvie INC. | $421.18 | 2021-2025 | Vraylar, Qulipta |
| Astrazeneca Pharmaceuticals Lp | $352.29 | 2020-2025 | Airsupra, Breztri, Farxiga |
| Janssen Pharmaceuticals, INC | $327.24 | 2019-2023 | Xarelto |
| Glaxosmithkline, LLC. | $221.77 | 2019-2021 | |
| Tela Bio, INC. | $157.88 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Takeda Pharmaceuticals U.S.A., INC. | $129.98 | 2019 | |
| Exact Sciences Corporation | $114.30 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $99.99 | 2021 | |
| Avanir Pharmaceuticals, INC. | $99.58 | 2019 | |
| Acadia Pharmaceuticals INC | $96.00 | 2019 | |
| Lundbeck LLC | $82.63 | 2020-2025 | Rexulti |
| Lilly USA, LLC | $79.18 | 2022-2025 | Zepbound, Kisunla, Mounjaro |
| Novartis Pharmaceuticals Corporation | $72.63 | 2019-2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Cotler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.